Unitaid’s Early Market Access Vehicle – an innovative demand-driven model to catalyze introduction of new optimal health products in low- and middle-income countries

Unitaid and RIGHT Foundation partner to accelerate access to health innovations for low- and middle-income countries

Developing child-friendly TB medicines

More tolerable treatments for drug-resistant TB

Expanded, shortened treatment options are now recommended for all populations with multidrug-resistant tuberculosis (MDR-TB).

Shorter TB prevention regimens (3HP/1HP)

Medicines that clear TB infection from a person’s system before it develops into active disease. 

TB medicines for children

Fruit-flavored, properly dosed medicines for preventing and treating all forms of tuberculosis (TB) in children.  

Diagnostic sequencing for tuberculosis

A novel class of diagnostic technology that can quickly identify resistance to multiple tuberculosis (TB) drugs and determine which drugs are likely to work best. 

Unitaid et la France